• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入性前列环素(PGI2)与吸入性一氧化氮治疗成人呼吸窘迫综合征的比较

Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.

作者信息

Zwissler B, Kemming G, Habler O, Kleen M, Merkel M, Haller M, Briegel J, Welte M, Peter K

机构信息

Department of Anesthesiology, Ludwig-Maximilians-Universität München, Germany.

出版信息

Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1671-7. doi: 10.1164/ajrccm.154.6.8970353.

DOI:10.1164/ajrccm.154.6.8970353
PMID:8970353
Abstract

Inhalation of nitric oxide (NO) and prostacyclin (PGI2) may induce selective pulmonary vasodilation and-by improving ventilation-perfusion ratio in ventilated areas of the lung-increase Pao2 in patients with acute lung injury. To assess the therapeutic efficacy of both compounds, dose-response curves were established in patients with adult respiratory distress syndrome (ARDS). Patients received both PGI2 (doses of 1, 10, and 25 ng/kg/min) and NO (concentrations of 1, 4, and 8 ppm). Cardiorespiratory parameters were assessed at control, at each drug concentration, and after withdrawal of NO and PGI2. PGI2 resulted in a significant, dose-dependent and selective reduction of pulmonary artery pressure (PAP) from 35.1 +/- 6.3 mm Hg at control to 33.1 +/- 4.8 (1 ng/kg/min), 31.3 +/- 4.8 mm Hg (10 ng/kg/min) and 29.6 +/- 4.5 mm Hg (25 ng/kg/min), respectively. Inhaled NO reduced PAP from 34.5 +/- 5.6 to 32.1 +/- 5.9 mm Hg at 4 ppm, and to 31.8 +/- 6.1 mm Hg at 8 ppm, respectively, with no effect at 1 ppm. Pao2/Flo2 ratio increased from 105 +/- 37 to 125 +/- 56 mm Hg (range of increase: 0 to 57 mm Hg) at PGI2 10 ng/kg/min and to 131 +/- 63 mm Hg (range: -5 to 89 mm Hg) at 25 ng/kg/min with no effect at 1 ng/kg/min. NO improved Pao2 (e.g., from 116 +/- 47 to 167 +/- 86 mm Hg at 8 ppm) and reduced intrapulmonary shunt at all doses tested. We conclude that both inhaled PGI2 and NO may induce selective pulmonary vasodilation and increase Pao2 in severe ARDS.

摘要

吸入一氧化氮(NO)和前列环素(PGI2)可诱导选择性肺血管舒张,并通过改善肺通气区域的通气/灌注比,提高急性肺损伤患者的动脉血氧分压(Pao2)。为评估这两种化合物的治疗效果,对成人呼吸窘迫综合征(ARDS)患者建立了剂量-反应曲线。患者分别接受PGI2(剂量为1、10和25 ng/kg/分钟)和NO(浓度为1、4和8 ppm)。在对照状态、每个药物浓度时以及停用NO和PGI2后评估心肺参数。PGI2导致肺动脉压(PAP)显著、剂量依赖性且选择性降低,从对照时的35.1±6.3 mmHg分别降至33.1±4.8(1 ng/kg/分钟)、31.3±4.8 mmHg(10 ng/kg/分钟)和29.6±4.5 mmHg(25 ng/kg/分钟)。吸入NO使PAP在4 ppm时从34.5±5.6降至32.1±5.9 mmHg,在8 ppm时降至31.8±6.1 mmHg,在1 ppm时无影响。在PGI2为10 ng/kg/分钟时,Pao2/Flo2比值从105±37升至125±56 mmHg(升高范围:0至57 mmHg),在25 ng/kg/分钟时升至131±63 mmHg(范围:-5至89 mmHg),在1 ng/kg/分钟时无影响。在所有测试剂量下,NO均改善了Pao2(例如,在8 ppm时从116±47升至167±86 mmHg)并减少了肺内分流。我们得出结论,吸入PGI2和NO均可诱导选择性肺血管舒张并提高重症ARDS患者的Pao2。

相似文献

1
Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.吸入性前列环素(PGI2)与吸入性一氧化氮治疗成人呼吸窘迫综合征的比较
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1671-7. doi: 10.1164/ajrccm.154.6.8970353.
2
Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.吸入一氧化氮与雾化前列环素在急性呼吸窘迫综合征中的直接比较。
Am J Respir Crit Care Med. 1996 Mar;153(3):991-6. doi: 10.1164/ajrccm.153.3.8630585.
3
Inhaled nitric oxide for the adult respiratory distress syndrome.吸入一氧化氮治疗成人呼吸窘迫综合征。
N Engl J Med. 1993 Feb 11;328(6):399-405. doi: 10.1056/NEJM199302113280605.
4
The role of inhaled prostacyclin in treating acute respiratory distress syndrome.吸入性前列环素在治疗急性呼吸窘迫综合征中的作用。
Ther Adv Respir Dis. 2015 Dec;9(6):302-12. doi: 10.1177/1753465815599345. Epub 2015 Aug 20.
5
[Gas exchange and hemodynamic effects of nitric oxide inhalation in patients with acute respiratory distress syndrome].[一氧化氮吸入对急性呼吸窘迫综合征患者气体交换及血流动力学的影响]
Med Clin (Barc). 1996 Jul 6;107(6):201-6.
6
Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome.雾化吸入前列腺素E1和一氧化氮对急性呼吸窘迫综合征患者心肺功能的影响
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1743-7. doi: 10.1164/ajrccm.157.6.9609017.
7
PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.前列环素气雾剂与一氧化氮用于低氧性肺血管收缩时的选择性肺血管舒张作用
Eur Surg Res. 1993;25(5):329-40. doi: 10.1159/000129297.
8
Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. The NO Almitrine Study Group.静脉注射烯丙哌三嗪联合吸入一氧化氮治疗急性呼吸窘迫综合征。一氧化氮 - 烯丙哌三嗪研究组。
Am J Respir Crit Care Med. 1998 Dec;158(6):1770-7. doi: 10.1164/ajrccm.158.6.9804066.
9
Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema.在犬肺微栓塞和油酸水肿模型中,吸入前列环素与吸入一氧化氮的效果比较
J Cardiothorac Vasc Anesth. 1995 Dec;9(6):634-40. doi: 10.1016/s1053-0770(05)80222-8.
10
Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep.吸入一氧化氮和雾化前列环素对麻醉绵羊缺氧性肺血管收缩的影响。
Crit Care Med. 1996 Nov;24(11):1841-8. doi: 10.1097/00003246-199611000-00014.

引用本文的文献

1
The Use of an Inspiration-Synchronized Vibrating Mesh Nebulizer for Prolonged Inhalative Iloprost Administration in Mechanically Ventilated Patients-An In Vitro Model.在机械通气患者中使用吸气同步振动网式雾化器进行伊洛前列素的长时间吸入给药——体外模型
Pharmaceutics. 2023 Aug 3;15(8):2080. doi: 10.3390/pharmaceutics15082080.
2
Right ventricle-specific therapies in acute respiratory distress syndrome: a scoping review.急性呼吸窘迫综合征的右心室特异性治疗:范围综述。
Crit Care. 2023 Mar 12;27(1):104. doi: 10.1186/s13054-023-04395-9.
3
Use of Aerosolized Prostacyclins in Critically Ill Patients and Association With Clinical Outcomes.
雾化前列环素在危重症患者中的应用及其与临床结局的关联。
Crit Care Explor. 2023 Jan 6;5(1):e0845. doi: 10.1097/CCE.0000000000000845. eCollection 2023 Jan.
4
Inhaled Nitric Oxide vs Epoprostenol During Acute Respiratory Failure: An Observational Target Trial Emulation.吸入一氧化氮与依前列醇治疗急性呼吸衰竭:一项观察性目标模拟试验。
Chest. 2022 Dec;162(6):1287-1296. doi: 10.1016/j.chest.2022.08.001. Epub 2022 Aug 8.
5
The Use of Inhaled Epoprostenol for Acute Respiratory Distress Syndrome Secondary Due To COVID-19: a Case Series.吸入依前列醇治疗新型冠状病毒肺炎继发急性呼吸窘迫综合征:病例系列
J Crit Care Med (Targu Mures). 2021 Nov 17;8(1):33-40. doi: 10.2478/jccm-2021-0037. eCollection 2022 Jan.
6
Endothelial Damage in Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征中的内皮损伤。
Int J Mol Sci. 2020 Nov 20;21(22):8793. doi: 10.3390/ijms21228793.
7
Physiological mechanism and spatial distribution of increased alveolar dead-space in early ARDS: An experimental study.早期急性呼吸窘迫综合征肺泡死腔增加的生理机制和空间分布:一项实验研究。
Acta Anaesthesiol Scand. 2021 Jan;65(1):100-108. doi: 10.1111/aas.13702. Epub 2020 Sep 28.
8
Inhaled epoprostenol utilization pattern after implementation of an administration policy.实施给药政策后吸入性依前列醇的使用模式
Proc (Bayl Univ Med Cent). 2019 Oct 14;33(1):10-14. doi: 10.1080/08998280.2019.1668668. eCollection 2020 Jan.
9
A Simple Effective Pharmacological Treatment of Hypoxemia During One-Lung Ventilation.一种用于单肺通气期间低氧血症的简单有效药物治疗方法。
J Clin Med. 2019 Jul 31;8(8):1139. doi: 10.3390/jcm8081139.
10
The Effects of Iloprost on Oxygenation During One-Lung Ventilation for Lung Surgery: A Randomized Controlled Trial.伊洛前列素对肺手术单肺通气期间氧合的影响:一项随机对照试验。
J Clin Med. 2019 Jul 5;8(7):982. doi: 10.3390/jcm8070982.